🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Steven Wang

Broad Institute

ORCID: 0000-0002-5019-5024

Also affiliated with Brigham and Women's Hospital, Massachusetts General Hospital, Center for Cancer Research, Center for Systems Biology, Stanford University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma (HNSCC).”.

Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma (HNSCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6015
N/A
0DataRank · unranked
7 citations

Nabil F. Saba, Denise J. Roe, Jessica R. Bauman, John M. Kaczmar, Aarti Bhatia +14 more

Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment

Nature Genetics(2024)10.1038/s41588-024-01890-9
N/A
0DataRank · unranked
72 citations

Jingyi Cao, Dennis Gong, Mark Gregory, Nicholas J Caldwell, Xunqin Yin +27 more

Pathways for macrophage uptake of cell-free circular RNAs

Molecular Cell(2024)10.1016/j.molcel.2024.04.022
N/A
0DataRank · unranked
18 citations

Brian T. Abe, Jie Liu, Feifei Zhao, Wenyan Lucy Zhang, Robert Chen +8 more